Evidence map›Paper›PMID 35398296›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report.

R Medhat, R El Lababidi, M Abdelsalam, A Nusair

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

R MedhatAssociate Staff Physician, Hospital Medicine, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE, p.o box 112412. Electronic address: MedhatR@ClevelandClinicAbuDhabi.ae.
R El LababidiAAHIVP, Senior Manager, Pharmacy Education and Training, Co-Director, Antimicrobial Stewardship Program, Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, UAE. p.o box 112412. Electronic address: ellabar@clevelandclinicabudhabi.ae.
M AbdelsalamPharmacy Intern, Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE, p.o. box 112412. Electronic address: AbdelsM2@ClevelandClinicAbuDhabi.ae.
A NusairProfessor of Medicine. John C. Edwards School of Medicine Marshall University, Huntington, West Virginia. Electronic address: nusair@marshall.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present, to our knowledge, the second case report of a 46-year old female who developed varicella-zoster virus (VZV) meningitis after BNT162b2 mRNA COVID-19 vaccination. The patient is immunocompetent and has no known predisposing risk factors for developing VZV meningitis. The patient received acyclovir therapy and subsequently had a complete recovery. We describe possible mechanisms of VZV meningitis after mRNA COVID-19 vaccination.

Indexed as

COVID-19Herpes ZosterMeningitisAdultBNT162 VaccineCOVID-19 VaccinesFemaleHerpesvirus 3, HumanHumansMiddle AgedRNA, MessengerVaccinationBNT162 VaccineCOVID-19 VaccinesRNA, MessengerBNT162b2 mRNACOVID-19COVID-19 vaccinationSARS-CoV-2Varicella-zoster virus

Identifiers

PMID35398296
PMCPMC9058432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.